Charco Neurotech

Cambridge, United Kingdom Founded: 2019 • Age: 7 yrs
Non-invasive wearable devices for Parkinsons management are developed.
Annual revenue - Latest available
Total funding $17.2M 6 rounds
Employees 22 Tracked headcount
Investors 9 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Charco Neurotech

Charco Neurotech is a company based in Cambridge (United Kingdom) founded in 2019. Charco Neurotech has raised $17.25 million across 6 funding rounds from investors including Imperial College London, Royal College of Art and Amadeus Capital Partners. The company has 22 employees as of February 29, 2024. Charco Neurotech operates in a competitive market with competitors including Empatica, Openwater, PhotoPharmics, PD Neurotechnology and Cala Health, among others.

  • Headquarter Cambridge, United Kingdom
  • Employees 22 as on 29 Feb, 2024
  • Stage Minicorn
  • Sectors
    Healthcare
    Technology
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Charco Neurotech Ltd
  • Date of Incorporation 03 Jun, 2019
  • Jurisdiction CAMBRIDGE, UNITED KINGDOM
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Technology → Extended, Virtual & Augmented Reality Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $17.25 M (USD)

    in 6 rounds

  • Latest Funding Round
    $695.85 K (USD), Seed

    Jun 27, 2024

  • Investors
  • Employee Count
    22

    as on Feb 29, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Charco Neurotech

Headcount 10-50
Employee Profiles 5
Employee Profiles
People
Keith Kicheol Park
EVP / R&D LEAD
People
Angie Nauful
General Manager
People
Andrew Mullen
Chief Executive Officer
People
Dahee Han
Creative Lead

Unlock access to complete

Funding Insights of Charco Neurotech

Charco Neurotech has successfully raised a total of $17.25M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $695.85 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Charco Neurotech

Charco Neurotech has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Imperial College London, Royal College of Art and Amadeus Capital Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage deep technology investments are made by Amadeus Capital.
Locked Locked Locked
Tech companies are invested in by Parkwalk venture capital firm.
Locked Locked Locked
Seed and Early stage VC firm investing in Japan
Locked Locked Locked
Premium access

Investor details for Charco Neurotech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Charco Neurotech

Investments
Premium access

Investment portfolio details for Charco Neurotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Charco Neurotech

Premium access

Detailed financials for Charco Neurotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Charco Neurotech Comparisons

Charco Neurotech Primary company
Description
Non-invasive wearable devices for Parkinson's management are...
Location
Cambridge, United Kingdom
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
22
As of 2024
Premium access

Peer comparison for Charco Neurotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Charco Neurotech

Charco Neurotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Empatica, Openwater, PhotoPharmics, PD Neurotechnology and Cala Health, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of a wrist band to monitor physiological signals
Locked Locked Locked
Provider of imaging technologies for medical diagnosis and treatments
Locked Locked Locked
Non-invasive phototherapy for Parkinson's disease is developed.
Locked Locked Locked
A wearable device is developed to monitor Parkinson's movement disorders.
Locked Locked Locked
Wearable neuromodulation devices for essential tremor relief are developed.
Locked Locked Locked
Non-invasive neuromodulation systems for depression treatment are provided.
Premium access

Detailed competitors of Charco Neurotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Charco Neurotech

Premium access

Complete news archive for Charco Neurotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charco Neurotech

Charco Neurotech was founded in 2019.

Charco Neurotech is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Charco Neurotech is a funded company, having raised a total of $17.25M across 6 funding rounds to date.

As of Feb 29, 2024, the latest employee count at Charco Neurotech is 22.

Developer of a non-invasive wearable device for people with Parkinsons. The company has developed a CUE1 device that utilizes pulsed cueing and vibrotactile stimulation to the peripheral nervous system that helps in the reductions of slowness and stiffness resulting in improved movement. The device can act as a medication reminder and helps in symptom tracking and monitoring. The platform also offers an app that is integrated with the device and allows users to instruct the device when to remind them to take their medicine.

Charco Neurotech's top competitors include Empatica, Openwater and Magnus Medical.

Charco Neurotech has 9 investors. Key investors include Imperial College London, Royal College of Art, Amadeus Capital Partners, Parkwalk, and UT-EC Japan.

The valuation of Charco Neurotech is $13.71M as of Jun 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available